




Searching News Database: Elan
Your search returned too many results! The most recent 500 items are shown below:
HSMN NewsFeed - 21 Sep 2023
Medtronic Diabetes announces CE Mark for new Simplera(TM) CGM with disposable all-in-one design
Medtronic Diabetes announces CE Mark for new Simplera(TM) CGM with disposable all-in-one design
HSMN NewsFeed - 30 Aug 2023
Alkermes Announces Settlement With Teva Related to VIVITROL(R) Patent Litigation
Alkermes Announces Settlement With Teva Related to VIVITROL(R) Patent Litigation
HSMN NewsFeed - 19 Jun 2023
Sirnaomics Advances STP705 for Squamous Cell Carcinoma In Situ into Late-Stage Clinical Development
Sirnaomics Advances STP705 for Squamous Cell Carcinoma In Situ into Late-Stage Clinical Development
HSMN NewsFeed - 13 Jun 2023
VA Oklahoma City Healthcare System Chooses ViewRay's MRIdian(R) MRI-Guided Radiation Therapy System
VA Oklahoma City Healthcare System Chooses ViewRay's MRIdian(R) MRI-Guided Radiation Therapy System
HSMN NewsFeed - 15 Mar 2023
Medtronic receives CE Mark approval for Affera(TM) Mapping and Ablation System to treat atrial arrhythmias
Medtronic receives CE Mark approval for Affera(TM) Mapping and Ablation System to treat atrial arrhythmias
HSMN NewsFeed - 17 Feb 2023
Medtronic Receives CE Mark for Extravascular Defibrillator System That Treats Abnormal Heart Rhythms
Medtronic Receives CE Mark for Extravascular Defibrillator System That Treats Abnormal Heart Rhythms
HSMN NewsFeed - 4 Jan 2023
Monica Shaw appointed CEO of Oncopeptides - Jakob Lindberg assumes position as Chief Scientific Officer
Monica Shaw appointed CEO of Oncopeptides - Jakob Lindberg assumes position as Chief Scientific Officer
HSMN NewsFeed - 17 Nov 2022
Upstaza(TM) Gene Therapy Granted Marketing Authorization for AADC deficiency by UK's MHRA
Upstaza(TM) Gene Therapy Granted Marketing Authorization for AADC deficiency by UK's MHRA
HSMN NewsFeed - 17 Oct 2022
Medtronic First to Receive FDA Approval for Pacing the Heart's Natural Conduction System
Medtronic First to Receive FDA Approval for Pacing the Heart's Natural Conduction System
HSMN NewsFeed - 23 Aug 2022
VA Houston Healthcare System Selects ViewRay to Expand Advanced Radiation Therapy Services
VA Houston Healthcare System Selects ViewRay to Expand Advanced Radiation Therapy Services
HSMN NewsFeed - 28 Jun 2022
Advanced NanoTherapies Announces Closing of Oversubscribed $7.2 Million Series A Financing
Advanced NanoTherapies Announces Closing of Oversubscribed $7.2 Million Series A Financing
HSMN NewsFeed - 22 Jun 2022
Angiex Strengthens its Leadership Team with the Appointment of Marty J. Duvall as Chief Executive Officer
Angiex Strengthens its Leadership Team with the Appointment of Marty J. Duvall as Chief Executive Officer
HSMN NewsFeed - 9 Jun 2022
VA Ann Arbor Healthcare System Selects ViewRay to Expand Advanced Radiation Therapy Services
VA Ann Arbor Healthcare System Selects ViewRay to Expand Advanced Radiation Therapy Services
HSMN NewsFeed - 2 Jun 2022
Henry Ford Health Becomes the First Center to Treat Patients with ViewRay's MRIdian A3i System
Henry Ford Health Becomes the First Center to Treat Patients with ViewRay's MRIdian A3i System
HSMN NewsFeed - 20 May 2022
PTC Therapeutics Receives Positive CHMP Opinion for Upstaza(TM) for the Treatment of AADC Deficiency
PTC Therapeutics Receives Positive CHMP Opinion for Upstaza(TM) for the Treatment of AADC Deficiency
HSMN NewsFeed - 13 May 2022
Medtronic receives FDA approval for latest generation drug-eluting coronary stent system
Medtronic receives FDA approval for latest generation drug-eluting coronary stent system
HSMN NewsFeed - 9 May 2022
BlueWind Medical Raises $64 Million to Fund Innovative Technology for Overactive Bladder (OAB) Treatment
BlueWind Medical Raises $64 Million to Fund Innovative Technology for Overactive Bladder (OAB) Treatment
HSMN NewsFeed - 3 May 2022
UCI Health Adopts ViewRay(R) MRIdian(R) MRI-Guided Radiation Therapy System
UCI Health Adopts ViewRay(R) MRIdian(R) MRI-Guided Radiation Therapy System
HSMN NewsFeed - 21 Apr 2022
Wallaby Acquires German Neurovascular Leader Phenox to Accelerate Global Expansion
Wallaby Acquires German Neurovascular Leader Phenox to Accelerate Global Expansion
HSMN NewsFeed - 20 Apr 2022
ZEISS Announces U.S. FDA Clearance of the QUATERA 700, a Revolution in Phaco Technology
ZEISS Announces U.S. FDA Clearance of the QUATERA 700, a Revolution in Phaco Technology
HSMN NewsFeed - 14 Apr 2022
NCCN Guidelines(R) Recommend VONJO(TM) (pacritinib) for the Treatment of Myeloproliferative Neoplasms
NCCN Guidelines(R) Recommend VONJO(TM) (pacritinib) for the Treatment of Myeloproliferative Neoplasms
HSMN NewsFeed - 28 Mar 2022
Jazz Pharmaceuticals Announces Agreement to Divest Sunosi(R) (solriamfetol) to Axsome Therapeutics
Jazz Pharmaceuticals Announces Agreement to Divest Sunosi(R) (solriamfetol) to Axsome Therapeutics
HSMN NewsFeed - 28 Feb 2022
Medtronic Announces Launch of NuVent(TM) Eustachian Tube Dilation Balloon
Medtronic Announces Launch of NuVent(TM) Eustachian Tube Dilation Balloon
HSMN NewsFeed - 2 Feb 2022
Medtronic announces first procedure in Europe with Hugo(TM) robotic-assisted surgery system
Medtronic announces first procedure in Europe with Hugo(TM) robotic-assisted surgery system
HSMN NewsFeed - 15 Dec 2021
ViewRay Receives 510(k) Clearance on Next Generation of MRIdian MRI-Guided Radiation Therapy Features
ViewRay Receives 510(k) Clearance on Next Generation of MRIdian MRI-Guided Radiation Therapy Features
HSMN NewsFeed - 15 Nov 2021
Medtronic Taps Top Digital and Healthcare Technology Leaders to Drive Company Transformation
Medtronic Taps Top Digital and Healthcare Technology Leaders to Drive Company Transformation
HSMN NewsFeed - 8 Nov 2021
BrainStorm Cell Therapeutics Expands Leadership Team to Support Clinical Development and Medical Affairs
BrainStorm Cell Therapeutics Expands Leadership Team to Support Clinical Development and Medical Affairs
HSMN NewsFeed - 25 Oct 2021
Helsinki University Hospital Selects MRIdian(R) System for Installation at Comprehensive Cancer Center
Helsinki University Hospital Selects MRIdian(R) System for Installation at Comprehensive Cancer Center
HSMN NewsFeed - 21 Oct 2021
Austin L. Chiang, M.D., M.P.H. Joins Medtronic As Chief Medical Officer for Gastrointestinal Business
Austin L. Chiang, M.D., M.P.H. Joins Medtronic As Chief Medical Officer for Gastrointestinal Business
HSMN NewsFeed - 11 Oct 2021
Medtronic Hugo(TM) Robotic-Assisted Surgery System Receives European CE Mark Approval
Medtronic Hugo(TM) Robotic-Assisted Surgery System Receives European CE Mark Approval
HSMN NewsFeed - 30 Sep 2021
Medtronic Expands Minimally Invasive Spine Surgery Ecosystem with Next-Generation Spinal Technologies
Medtronic Expands Minimally Invasive Spine Surgery Ecosystem with Next-Generation Spinal Technologies
HSMN NewsFeed - 27 Sep 2021
First Procedure in Asia-Pacific Performed with Medtronic Hugo(TM) Robotic-Assisted Surgery System
First Procedure in Asia-Pacific Performed with Medtronic Hugo(TM) Robotic-Assisted Surgery System
HSMN NewsFeed - 9 Sep 2021
Obsidian Therapeutics Announces Closing of $115 Million Series B Financing
Obsidian Therapeutics Announces Closing of $115 Million Series B Financing
HSMN NewsFeed - 8 Sep 2021
atHeart Medical Appoints Seasoned Medtech Executive Andrew Cleeland to Board of Directors
atHeart Medical Appoints Seasoned Medtech Executive Andrew Cleeland to Board of Directors
HSMN NewsFeed - 20 Aug 2021
Cardiac Dimensions(R) Announces Launch of Its Optimized U.S. Pivotal Trial - The EMPOWER Trial
Cardiac Dimensions(R) Announces Launch of Its Optimized U.S. Pivotal Trial - The EMPOWER Trial
HSMN NewsFeed - 19 Aug 2021
Stryker Heads To Truist Field To Educate Charlotte Knights Fans On Mako SmartRobotics(TM) Technology
Stryker Heads To Truist Field To Educate Charlotte Knights Fans On Mako SmartRobotics(TM) Technology
HSMN NewsFeed - 2 Aug 2021
Alkermes Receives FDA Fast Track Designation for Nemvaleukin Alfa for the Treatment of Mucosal Melanoma
Alkermes Receives FDA Fast Track Designation for Nemvaleukin Alfa for the Treatment of Mucosal Melanoma
HSMN NewsFeed - 28 Jul 2021
Medtronic Announces FDA Clearance and Results of Artificial Intelligence Algorithms for Cardiac Monitoring
Medtronic Announces FDA Clearance and Results of Artificial Intelligence Algorithms for Cardiac Monitoring
HSMN NewsFeed - 21 Jul 2021
FDA Grants Breakthrough Designation to Synapse Biomedical's TransAeris(R) System
FDA Grants Breakthrough Designation to Synapse Biomedical's TransAeris(R) System
HSMN NewsFeed - 13 Jul 2021
Prime Medicine Launches with $315 Million Financing to Deliver on the Promise of Prime Editing
Prime Medicine Launches with $315 Million Financing to Deliver on the Promise of Prime Editing
HSMN NewsFeed - 7 Jun 2021
FDA Approves First-of-its-Kind SenSight(TM) Directional Lead System for DBS Therapy
FDA Approves First-of-its-Kind SenSight(TM) Directional Lead System for DBS Therapy
HSMN NewsFeed - 26 May 2021
Medtronic Secures Two CE Mark Approvals for Guardian 4 Sensor & for InPen MDI Smart Insulin Pen
Medtronic Secures Two CE Mark Approvals for Guardian 4 Sensor & for InPen MDI Smart Insulin Pen
HSMN NewsFeed - 27 Apr 2021
Medtronic Receives FDA Breakthrough Designation for the Emprint(TM) Ablation Catheter Kit
Medtronic Receives FDA Breakthrough Designation for the Emprint(TM) Ablation Catheter Kit
HSMN NewsFeed - 21 Apr 2021
Medtronic Receives U.S. FDA Approval for Pipeline(TM) Flex Embolization Device with Shield Technology(TM)
Medtronic Receives U.S. FDA Approval for Pipeline(TM) Flex Embolization Device with Shield Technology(TM)
HSMN NewsFeed - 20 Apr 2021
Lilly and Incyte's Baricitinib Improved Hair Regrowth for Alopecia Areata Patients in Second Phase 3 Study
Lilly and Incyte's Baricitinib Improved Hair Regrowth for Alopecia Areata Patients in Second Phase 3 Study
HSMN NewsFeed - 30 Mar 2021
PTC Therapeutics Announces the European Approval of Evrysdi(TM) for the Treatment of Spinal Muscular Atrophy
PTC Therapeutics Announces the European Approval of Evrysdi(TM) for the Treatment of Spinal Muscular Atrophy
HSMN NewsFeed - 22 Mar 2021
Medtronic Receives CE Mark Approval for SenSight(TM) Directional Lead System for DBS Therapy
Medtronic Receives CE Mark Approval for SenSight(TM) Directional Lead System for DBS Therapy
HSMN NewsFeed - 18 Mar 2021
Boston Scientific Receives FDA Approval for TheraSphere(TM) Y-90 Glass Microspheres
Boston Scientific Receives FDA Approval for TheraSphere(TM) Y-90 Glass Microspheres
HSMN NewsFeed - 11 Mar 2021
Alkermes Announces FDA Orphan Drug Designation for Nemvaleukin Alfa for Treatment of Mucosal Melanoma
Alkermes Announces FDA Orphan Drug Designation for Nemvaleukin Alfa for Treatment of Mucosal Melanoma
HSMN NewsFeed - 18 Feb 2021
Medtronic Receives FDA Approval for Expanded MRI Labeling of InterStim(TM) SureScan(TM) MRI Leads
Medtronic Receives FDA Approval for Expanded MRI Labeling of InterStim(TM) SureScan(TM) MRI Leads
HSMN NewsFeed - 18 Feb 2021
OncoSec Appoints Bridget O'Keeffe, Ph.D. as Vice President of Clinical Development
OncoSec Appoints Bridget O'Keeffe, Ph.D. as Vice President of Clinical Development
HSMN NewsFeed - 17 Feb 2021
Medtronic Announces Voluntary Recall of Unused Valiant Navion(TM) Thoracic Stent Graft System
Medtronic Announces Voluntary Recall of Unused Valiant Navion(TM) Thoracic Stent Graft System
HSMN NewsFeed - 26 Jan 2021
The Henry Ford Cancer Institute Installs its Second ViewRay MRIdian(R) Linac
The Henry Ford Cancer Institute Installs its Second ViewRay MRIdian(R) Linac
HSMN NewsFeed - 18 Dec 2020
Nuvo Pharmaceuticals(R) Announces Corporate Rebranding as Miravo Healthcare(TM)
Nuvo Pharmaceuticals(R) Announces Corporate Rebranding as Miravo Healthcare(TM)
HSMN NewsFeed - 1 Dec 2020
Actinium Appoints Mary Mei Chen, M.D., Ph.D. as Vice President of Clinical Development
Actinium Appoints Mary Mei Chen, M.D., Ph.D. as Vice President of Clinical Development
HSMN NewsFeed - 12 Nov 2020
Synthetic Biologics Welcomes Senior Biotech Executive John Monahan, PhD, to Board of Directors
Synthetic Biologics Welcomes Senior Biotech Executive John Monahan, PhD, to Board of Directors
HSMN NewsFeed - 10 Nov 2020
Cytocom, Inc. Appoints Taunia Markvicka, PharmD., MBA, Chief Operating Officer
Cytocom, Inc. Appoints Taunia Markvicka, PharmD., MBA, Chief Operating Officer
HSMN NewsFeed - 9 Nov 2020
DTx Pharma Announces Appointment of Denise Bevers as Chief Operating Officer
DTx Pharma Announces Appointment of Denise Bevers as Chief Operating Officer
HSMN NewsFeed - 6 Nov 2020
BioElectronics' ActiPatch(R) Therapy To Be Marketed By DonJoy(R) Advantage
BioElectronics' ActiPatch(R) Therapy To Be Marketed By DonJoy(R) Advantage
HSMN NewsFeed - 5 Nov 2020
Endo Announces Strategic Actions to Further Position the Company for Long-Term Success
Endo Announces Strategic Actions to Further Position the Company for Long-Term Success
HSMN NewsFeed - 3 Nov 2020
Aethlon Announces Appointment of Charles J. Fisher, Jr., M.D. as Chief Executive Officer
Aethlon Announces Appointment of Charles J. Fisher, Jr., M.D. as Chief Executive Officer
HSMN NewsFeed - 26 Oct 2020
Jazz Pharmaceuticals Acquires SpringWorks Therapeutics' FAAH Inhibitor Program
Jazz Pharmaceuticals Acquires SpringWorks Therapeutics' FAAH Inhibitor Program
HSMN NewsFeed - 14 Oct 2020
Louis Stokes Cleveland VA Medical Center Purchases ViewRay's MRIdian Linac for MRI-Guided Radiation Therapy
Louis Stokes Cleveland VA Medical Center Purchases ViewRay's MRIdian Linac for MRI-Guided Radiation Therapy
HSMN NewsFeed - 6 Oct 2020
Medtronic Announces First Patient Implanted in ELITE Study of InterStim(TM) Micro
Medtronic Announces First Patient Implanted in ELITE Study of InterStim(TM) Micro
HSMN NewsFeed - 23 Sep 2020
Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen's COVID-19 Vaccine Candidate
Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen's COVID-19 Vaccine Candidate
HSMN NewsFeed - 10 Sep 2020
Medtronic Study Finds Opioid-Induced Respiratory Depression in the Hospital More Common and Costly
Medtronic Study Finds Opioid-Induced Respiratory Depression in the Hospital More Common and Costly
HSMN NewsFeed - 13 Aug 2020
Dartmouth-Hitchcock Health Begins Patient Treatments with ViewRay's MRIdian Linac
Dartmouth-Hitchcock Health Begins Patient Treatments with ViewRay's MRIdian Linac
HSMN NewsFeed - 23 Jul 2020
Quadriga BioSciences Initiates Clinical Trial of Innovative, Targeted Treatment for Brain Cancers
Quadriga BioSciences Initiates Clinical Trial of Innovative, Targeted Treatment for Brain Cancers
HSMN NewsFeed - 10 Jul 2020
Sedana Medical Announces Positive Top Line Result in Pivotal IsoConDa Study
Sedana Medical Announces Positive Top Line Result in Pivotal IsoConDa Study
HSMN NewsFeed - 30 Jun 2020
MedAlliance Gains CE Mark Approval for Coronary SELUTION SLR(TM) Sirolimus Drug Eluting Balloon
MedAlliance Gains CE Mark Approval for Coronary SELUTION SLR(TM) Sirolimus Drug Eluting Balloon
HSMN NewsFeed - 23 Jun 2020
Polynoma Receives FDA Fast Track Designation for its Melanoma Cancer Vaccine Seviprotimut-L
Polynoma Receives FDA Fast Track Designation for its Melanoma Cancer Vaccine Seviprotimut-L
HSMN NewsFeed - 29 May 2020
XTANDI(R) (enzalutamide) Approved by Japan MHLW for the Treatment of Prostate Cancer with Distant Metastasis
XTANDI(R) (enzalutamide) Approved by Japan MHLW for the Treatment of Prostate Cancer with Distant Metastasis
HSMN NewsFeed - 27 May 2020
Providence Portland Medical Center Begins Patient Treatments with ViewRay's MRIdian Linac
Providence Portland Medical Center Begins Patient Treatments with ViewRay's MRIdian Linac
HSMN NewsFeed - 26 May 2020
Elevar Therapeutics Appoints Mark Gelder, M.D. as Global Head of Medical Affairs
Elevar Therapeutics Appoints Mark Gelder, M.D. as Global Head of Medical Affairs
HSMN NewsFeed - 22 May 2020
Centerline Biomedical Appoints Key Physician Thought Leaders and Executives as Advisors
Centerline Biomedical Appoints Key Physician Thought Leaders and Executives as Advisors
HSMN NewsFeed - 23 Apr 2020
R2 Technologies Receives $10M Second Tranche Investment for Landmark CryoAesthetic Technology
R2 Technologies Receives $10M Second Tranche Investment for Landmark CryoAesthetic Technology
HSMN NewsFeed - 15 Apr 2020
Indivumed Launches Global Oncology Alliance For Personalized Medicine ("Onco AI-Med")
Indivumed Launches Global Oncology Alliance For Personalized Medicine ("Onco AI-Med")
HSMN NewsFeed - 26 Mar 2020
Immunexpress Receives CE Mark and Signs European Commercialization Partnership for SeptiCyte(R) RAPID
Immunexpress Receives CE Mark and Signs European Commercialization Partnership for SeptiCyte(R) RAPID
HSMN NewsFeed - 25 Mar 2020
Elevar Therapeutics Acquires Global Rights to European Approved Apealea(R) from Oasmia Pharmaceutical
Elevar Therapeutics Acquires Global Rights to European Approved Apealea(R) from Oasmia Pharmaceutical
HSMN NewsFeed - 24 Mar 2020
Apexigen Completes $123 Million Series C Financing To Advance Clinical Pipeline
Apexigen Completes $123 Million Series C Financing To Advance Clinical Pipeline
HSMN NewsFeed - 16 Mar 2020
ADVANZ PHARMA Corp. Limited to Acquire Specialty Pharmaceutical Company Correvio Pharma Corp.
ADVANZ PHARMA Corp. Limited to Acquire Specialty Pharmaceutical Company Correvio Pharma Corp.
HSMN NewsFeed - 16 Mar 2020
Lilly Receives FDA Breakthrough Therapy Designation for Baricitinib for the Treatment of Alopecia Areata
Lilly Receives FDA Breakthrough Therapy Designation for Baricitinib for the Treatment of Alopecia Areata
HSMN NewsFeed - 14 Feb 2020
Biocept Appoints Cory J. Dunn Senior Vice President of Commercial Operations
Biocept Appoints Cory J. Dunn Senior Vice President of Commercial Operations
HSMN NewsFeed - 17 Jan 2020
SkinMedica(R) Launches New Instant Bright Eye Cream For Immediate, Visible Results
SkinMedica(R) Launches New Instant Bright Eye Cream For Immediate, Visible Results
HSMN NewsFeed - 19 Dec 2019
Michigan Community Hospital Begins Patient Treatments with ViewRay's MRIdian Linac
Michigan Community Hospital Begins Patient Treatments with ViewRay's MRIdian Linac
HSMN NewsFeed - 20 Nov 2019
First Cryoballoon Ablation Procedures Performed Using the VersaCross(R) Transseptal Solution
First Cryoballoon Ablation Procedures Performed Using the VersaCross(R) Transseptal Solution
HSMN NewsFeed - 18 Nov 2019
Allergan(R) Announces First Annual National BOTOX(R) Cosmetic (onabotulinumtoxinA) Day
Allergan(R) Announces First Annual National BOTOX(R) Cosmetic (onabotulinumtoxinA) Day
HSMN NewsFeed - 30 Oct 2019
Biogen and Alkermes Announce FDA Approval of VUMERITY(TM) (diroximel fumarate) for Multiple Sclerosis
Biogen and Alkermes Announce FDA Approval of VUMERITY(TM) (diroximel fumarate) for Multiple Sclerosis
HSMN NewsFeed - 28 Oct 2019
Endo Aesthetics Launches New Campaign Elevating Artistry Through Scientific Innovation
Endo Aesthetics Launches New Campaign Elevating Artistry Through Scientific Innovation
HSMN NewsFeed - 30 Sep 2019
Endo Announces Successful Culmination of Litigation Regarding FDA Compounding Policy
Endo Announces Successful Culmination of Litigation Regarding FDA Compounding Policy
HSMN NewsFeed - 13 Sep 2019
Abbott's Revolutionary FreeStyle(R) Libre System Now Reimbursed in the Two Largest Provinces in Canada
Abbott's Revolutionary FreeStyle(R) Libre System Now Reimbursed in the Two Largest Provinces in Canada
HSMN NewsFeed - 3 Sep 2019
Allergan Receives FDA Approval of Juvéderm VOLUMA(R) XC For Mid-Face Injection Via Cannula
Allergan Receives FDA Approval of Juvéderm VOLUMA(R) XC For Mid-Face Injection Via Cannula
HSMN NewsFeed - 2 Sep 2019
Valo Therapeutics Acquires PeptiENV Technology from the University of Helsinki
Valo Therapeutics Acquires PeptiENV Technology from the University of Helsinki
HSMN NewsFeed - 30 Aug 2019
Allergan Announces Settlement with Two Ohio Plaintiffs in Federal Opioid Litigation
Allergan Announces Settlement with Two Ohio Plaintiffs in Federal Opioid Litigation
HSMN NewsFeed - 26 Aug 2019
Priya Chaturvedi, Ph.D., Appointed Vice President of Global Clinical Quality Assurance at Eisai Inc.
Priya Chaturvedi, Ph.D., Appointed Vice President of Global Clinical Quality Assurance at Eisai Inc.
HSMN NewsFeed - 12 Aug 2019
Shimadzu Medical Systems receives FDA 510(k) for the FLUOROspeed X1 RF system
Shimadzu Medical Systems receives FDA 510(k) for the FLUOROspeed X1 RF system
HSMN NewsFeed - 24 Jul 2019
Allergan Voluntarily Recalls BIOCELL(R) Textured Breast Implants and Tissue Expanders
Allergan Voluntarily Recalls BIOCELL(R) Textured Breast Implants and Tissue Expanders
HSMN NewsFeed - 15 Jul 2019
Alkermes Expands Planned New Drug Application for ALKS 3831 to Include Treatment of Bipolar I Disorder
Alkermes Expands Planned New Drug Application for ALKS 3831 to Include Treatment of Bipolar I Disorder
HSMN NewsFeed - 21 Jun 2019
FDA Approves BOTOX(R) (onabotulinumtoxinA) for Pediatric Patients with Upper Limb Spasticity
FDA Approves BOTOX(R) (onabotulinumtoxinA) for Pediatric Patients with Upper Limb Spasticity
HSMN NewsFeed - 13 Jun 2019
Medical Fish Skin Company Kerecis Limited Completes $16 Million Series C Offering
Medical Fish Skin Company Kerecis Limited Completes $16 Million Series C Offering
HSMN NewsFeed - 11 Jun 2019
Thommen Medical USA Announces Leadership Changes To Drive New Market Position
Thommen Medical USA Announces Leadership Changes To Drive New Market Position
HSMN NewsFeed - 5 Jun 2019
FDA Premarket Approval Granted for DT MedTech's Hintermann Series H3(TM) Total Ankle Replacement System
FDA Premarket Approval Granted for DT MedTech's Hintermann Series H3(TM) Total Ankle Replacement System
HSMN NewsFeed - 31 May 2019
Iovance Biotherapeutics Expands Partnership with WuXi Advanced Therapies Business
Iovance Biotherapeutics Expands Partnership with WuXi Advanced Therapies Business
HSMN NewsFeed - 24 Apr 2019
Xstrahl Spotlights Full Range of X-Ray Therapy and Radiation Research Systems at ESTRO 2019
Xstrahl Spotlights Full Range of X-Ray Therapy and Radiation Research Systems at ESTRO 2019
HSMN NewsFeed - 18 Apr 2019
ViewRay Partners with Leading Canadian Distributor to Bring MRI-guided Radiation Therapy to Canada
ViewRay Partners with Leading Canadian Distributor to Bring MRI-guided Radiation Therapy to Canada
HSMN NewsFeed - 10 Apr 2019
OncoSec Announces New Technology to Treat Deep Visceral Lesions with IL-12
OncoSec Announces New Technology to Treat Deep Visceral Lesions with IL-12
HSMN NewsFeed - 9 Apr 2019
FDA Clears VITROS(R) XT Chemistry Product Slides from Ortho Clinical Diagnostics
FDA Clears VITROS(R) XT Chemistry Product Slides from Ortho Clinical Diagnostics
HSMN NewsFeed - 18 Mar 2019
Allergan Announces FDA Approval of AVYCAZ(R) (ceftazidime and avibactam) for Pediatric Patients
Allergan Announces FDA Approval of AVYCAZ(R) (ceftazidime and avibactam) for Pediatric Patients
HSMN NewsFeed - 13 Mar 2019
Alvotech Enrolls First Patient in Clinical Phase III Study Involving Biosimilar Version of HUMIRA(R)
Alvotech Enrolls First Patient in Clinical Phase III Study Involving Biosimilar Version of HUMIRA(R)
HSMN NewsFeed - 11 Mar 2019
Allergan Announces FDA Acceptance of New Drug Application for Ubrogepant for the Acute Treatment of Migraine
Allergan Announces FDA Acceptance of New Drug Application for Ubrogepant for the Acute Treatment of Migraine
HSMN NewsFeed - 11 Mar 2019
IRRAS Strengthens Executive Team With Addition of Dr. Vinny Podichetty as Vice President of Clinical Affairs
IRRAS Strengthens Executive Team With Addition of Dr. Vinny Podichetty as Vice President of Clinical Affairs
HSMN NewsFeed - 22 Jan 2019
World's First MRIdian Center Celebrates Five Years of MRI-Guided Radiation Treatments
World's First MRIdian Center Celebrates Five Years of MRI-Guided Radiation Treatments
HSMN NewsFeed - 21 Dec 2018
Mallinckrodt And NPXe Announce First Patient Enrolled In Phase 3 Trial Of Inhaled Xenon Gas Therapy
Mallinckrodt And NPXe Announce First Patient Enrolled In Phase 3 Trial Of Inhaled Xenon Gas Therapy
HSMN NewsFeed - 20 Dec 2018
Kypha Secures $4M Series A Funding to Accelerate First-in-Class Diagnostic Platform Commercialization
Kypha Secures $4M Series A Funding to Accelerate First-in-Class Diagnostic Platform Commercialization
HSMN NewsFeed - 10 Dec 2018
Perrigo Announces the Launch of an AB Rated Generic Version of Topicort(R) Topical Spray 0.25%
Perrigo Announces the Launch of an AB Rated Generic Version of Topicort(R) Topical Spray 0.25%
HSMN NewsFeed - 29 Nov 2018
Nuvo Pharmaceuticals(TM) Declared Winning Bidder to Acquire Commercial Products from Aralez Pharmaceuticals
Nuvo Pharmaceuticals(TM) Declared Winning Bidder to Acquire Commercial Products from Aralez Pharmaceuticals
HSMN NewsFeed - 26 Nov 2018
Perrigo Announces Tentative FDA Approval For The First To File Generic Version Of Ultravate(R) Lotion 0.05%
Perrigo Announces Tentative FDA Approval For The First To File Generic Version Of Ultravate(R) Lotion 0.05%
HSMN NewsFeed - 13 Nov 2018
STERIBITE(R) Announces FDA Clearance of the Steribite Disposable Kerrison Rongeur
STERIBITE(R) Announces FDA Clearance of the Steribite Disposable Kerrison Rongeur
HSMN NewsFeed - 5 Nov 2018
Biocept Announces New Executive Hires to its Sales and Marketing Organization
Biocept Announces New Executive Hires to its Sales and Marketing Organization
HSMN NewsFeed - 29 Oct 2018
OncoSec Appoints Kellie Malloy Foerter as Chief Clinical Development Officer
OncoSec Appoints Kellie Malloy Foerter as Chief Clinical Development Officer
HSMN NewsFeed - 26 Oct 2018
Mayne Pharma Acquires FDA-approved halobetasol foam, Complementing US Dermatology Portfolio
Mayne Pharma Acquires FDA-approved halobetasol foam, Complementing US Dermatology Portfolio
HSMN NewsFeed - 4 Oct 2018
Allergan Receives FDA Clearance To Treat Area Below The Jawline With CoolSculpting(R)
Allergan Receives FDA Clearance To Treat Area Below The Jawline With CoolSculpting(R)
HSMN NewsFeed - 2 Oct 2018
ViewRay Appoints Industry Veteran James Alecxih as Chief Commercial Officer
ViewRay Appoints Industry Veteran James Alecxih as Chief Commercial Officer
HSMN NewsFeed - 1 Oct 2018
Perrigo Confirms Patent Challenge for Generic Version of Jublia(R) Topical Solution 10%
Perrigo Confirms Patent Challenge for Generic Version of Jublia(R) Topical Solution 10%
HSMN NewsFeed - 14 Sep 2018
Allergan to Acquire Bonti Adding New Neurotoxin Programs to Medical Aesthetics Pipeline
Allergan to Acquire Bonti Adding New Neurotoxin Programs to Medical Aesthetics Pipeline
HSMN NewsFeed - 10 Sep 2018
Biocept Names Edwin C. Hendrick as Senior Vice President, Chief Commercial Officer
Biocept Names Edwin C. Hendrick as Senior Vice President, Chief Commercial Officer
HSMN NewsFeed - 28 Aug 2018
Study Shows Improved Quality of Life and Reduced Symptoms In Patients Treated with Medtronic Cryoballoon
Study Shows Improved Quality of Life and Reduced Symptoms In Patients Treated with Medtronic Cryoballoon
HSMN NewsFeed - 23 Aug 2018
Mallinckrodt And NPXe Announce FDA Fast Track Designation For Phase 3 Trial Of Inhaled Xenon Gas Therapy
Mallinckrodt And NPXe Announce FDA Fast Track Designation For Phase 3 Trial Of Inhaled Xenon Gas Therapy
HSMN NewsFeed - 15 Aug 2018
Medtronic Announces Commercial Launch of the IN.PACT(TM) Admiral(TM) Drug-Coated Balloon in Japan
Medtronic Announces Commercial Launch of the IN.PACT(TM) Admiral(TM) Drug-Coated Balloon in Japan
HSMN NewsFeed - 9 Aug 2018
Perrigo Expands OTC Growth Strategy With Rx-To-OTC Switch Licensing For Nasonex(R)
Perrigo Expands OTC Growth Strategy With Rx-To-OTC Switch Licensing For Nasonex(R)
HSMN NewsFeed - 19 Jul 2018
Olympus Appoints New Director of Medical and Surgical Business for the UK and Ireland
Olympus Appoints New Director of Medical and Surgical Business for the UK and Ireland
HSMN NewsFeed - 13 Jul 2018
Kypha Acquires Biosensia - Expands First-in-Class Immune Status Monitoring Platforms
Kypha Acquires Biosensia - Expands First-in-Class Immune Status Monitoring Platforms
HSMN NewsFeed - 9 Jul 2018
Polaris Announces Drs. James Allison and Padmanee Sharma Joining its Scientific Advisory Board
Polaris Announces Drs. James Allison and Padmanee Sharma Joining its Scientific Advisory Board
HSMN NewsFeed - 20 Jun 2018
Medtronic Announces Second Bone Cement Solution Indicated for Treating Sacral Fractures
Medtronic Announces Second Bone Cement Solution Indicated for Treating Sacral Fractures
HSMN NewsFeed - 15 Jun 2018
Medtronic Receives FDA Approval for 200mm & 250mm IN.PACT(TM) Admiral(TM) Drug Coated Balloons
Medtronic Receives FDA Approval for 200mm & 250mm IN.PACT(TM) Admiral(TM) Drug Coated Balloons
HSMN NewsFeed - 13 Jun 2018
Elbit Systems' Surgeon-Centered Visualization Spin-Off, Beyeonics, Raises $11.5 Million
Elbit Systems' Surgeon-Centered Visualization Spin-Off, Beyeonics, Raises $11.5 Million
HSMN NewsFeed - 11 Jun 2018
IO Biotech Appoints Kathleen Sereda Glaub as Member of Board of Directors
IO Biotech Appoints Kathleen Sereda Glaub as Member of Board of Directors
HSMN NewsFeed - 22 May 2018
Varian Notifies Sirtex It Will Not Submit a Counterproposal to Competing Bid
Varian Notifies Sirtex It Will Not Submit a Counterproposal to Competing Bid
HSMN NewsFeed - 8 May 2018
Sensus Healthcare Appoints Dr. Isabelle Raymond as Vice President, Clinical Development
Sensus Healthcare Appoints Dr. Isabelle Raymond as Vice President, Clinical Development
HSMN NewsFeed - 26 Apr 2018
Endo to Acquire Somerset Therapeutics and Business of Affiliate Wintac Limited
Endo to Acquire Somerset Therapeutics and Business of Affiliate Wintac Limited
HSMN NewsFeed - 23 Apr 2018
Surmodics Announces FDA Clearance of a New .018” Low-Profile PTA Balloon Dilation Catheter
Surmodics Announces FDA Clearance of a New .018” Low-Profile PTA Balloon Dilation Catheter
HSMN NewsFeed - 18 Apr 2018
ViewRay Unveils New Soft Tissue Visualization Technologies to Further Advance MR Image-Guided Radiotherapy
ViewRay Unveils New Soft Tissue Visualization Technologies to Further Advance MR Image-Guided Radiotherapy
HSMN NewsFeed - 11 Apr 2018
Sysmex Inostics: OncoBEAM(TM) RAS CRC Liquid Biopsy Test Now Reimbursed in Germany by BARMER
Sysmex Inostics: OncoBEAM(TM) RAS CRC Liquid Biopsy Test Now Reimbursed in Germany by BARMER
HSMN NewsFeed - 2 Apr 2018
Abeona Therapeutics Appoints Carsten Thiel, Ph.D., as Chief Executive Officer
Abeona Therapeutics Appoints Carsten Thiel, Ph.D., as Chief Executive Officer
HSMN NewsFeed - 2 Mar 2018
Mylan to Introduce Two New Cost-Saving HIV Combination Treatments in the U.S.
Mylan to Introduce Two New Cost-Saving HIV Combination Treatments in the U.S.
HSMN NewsFeed - 27 Feb 2018
Amgen Receives Positive CHMP Opinion For Delivery System Of Neulasta(R) (pegfilgrastim)
Amgen Receives Positive CHMP Opinion For Delivery System Of Neulasta(R) (pegfilgrastim)
HSMN NewsFeed - 21 Feb 2018
Medtronic Introduces MiniMed(TM) Mio(TM) Advance Infusion Set for People with Diabetes
Medtronic Introduces MiniMed(TM) Mio(TM) Advance Infusion Set for People with Diabetes
HSMN NewsFeed - 7 Feb 2018
Abbott's App for FreeStyle(R) Libre System Now Available in Europe for Both iPhone and Android
Abbott's App for FreeStyle(R) Libre System Now Available in Europe for Both iPhone and Android
HSMN NewsFeed - 24 Jan 2018
Perrigo Announces Final FDA Approval Of A Generic Version Of Estrace(R) Cream
Perrigo Announces Final FDA Approval Of A Generic Version Of Estrace(R) Cream
HSMN NewsFeed - 24 Jan 2018
Perrigo Announces Final FDA Approval And Launch Of An AB Rated Generic Version Of Epiduo(R) Gel
Perrigo Announces Final FDA Approval And Launch Of An AB Rated Generic Version Of Epiduo(R) Gel
HSMN NewsFeed - 18 Dec 2017
Allergan Announces Promotion of Wayne Swanton to Executive Vice President, Global Operations
Allergan Announces Promotion of Wayne Swanton to Executive Vice President, Global Operations
HSMN NewsFeed - 7 Dec 2017
John Walsh, M.D. Joins EMD Serono as Vice President of Neurology & Immunology, US Medical Affairs
John Walsh, M.D. Joins EMD Serono as Vice President of Neurology & Immunology, US Medical Affairs
HSMN NewsFeed - 5 Dec 2017
OncoSec Announces Promotion of Christopher G. Twitty, Ph.D. to Chief Scientific Officer
OncoSec Announces Promotion of Christopher G. Twitty, Ph.D. to Chief Scientific Officer
HSMN NewsFeed - 4 Dec 2017
Merck's Mavenclad (Cladribine Tablets) Approved for Relapsing-Remitting Multiple Sclerosis in Canada
Merck's Mavenclad (Cladribine Tablets) Approved for Relapsing-Remitting Multiple Sclerosis in Canada
HSMN NewsFeed - 27 Nov 2017
Perrigo Announces the Launch of an AB Rated Generic Version of Exalgo(R) 32mg Extended Release Tablets
Perrigo Announces the Launch of an AB Rated Generic Version of Exalgo(R) 32mg Extended Release Tablets
HSMN NewsFeed - 10 Nov 2017
Elanco, Aratana Announce Positive Opinion on GALLIPRANT(R) (grapiprant tablets) in Europe
Elanco, Aratana Announce Positive Opinion on GALLIPRANT(R) (grapiprant tablets) in Europe
HSMN NewsFeed - 9 Nov 2017
NICE Recommends Mavenclad (Cladribine Tablets) for Highly Active Multiple Sclerosis
NICE Recommends Mavenclad (Cladribine Tablets) for Highly Active Multiple Sclerosis
HSMN NewsFeed - 3 Nov 2017
ViewRay's MRIdian Linac Selected as MR-Guided Radiotherapy System in Danish Tender
ViewRay's MRIdian Linac Selected as MR-Guided Radiotherapy System in Danish Tender
HSMN NewsFeed - 2 Nov 2017
Perrigo Announces Tentative FDA Approval for a First-to-File Generic Version of Picato(R) Gel 0.05%
Perrigo Announces Tentative FDA Approval for a First-to-File Generic Version of Picato(R) Gel 0.05%
HSMN NewsFeed - 26 Oct 2017
Perrigo Announces Patent Litigation Settlement for the Generic Version of Onexton(R) Gel
Perrigo Announces Patent Litigation Settlement for the Generic Version of Onexton(R) Gel
HSMN NewsFeed - 25 Oct 2017
Sobi: Alprolix(R) Approved in the Kingdom of Saudi Arabia for the Treatment of Haemophilia B
Sobi: Alprolix(R) Approved in the Kingdom of Saudi Arabia for the Treatment of Haemophilia B
HSMN NewsFeed - 10 Oct 2017
Allergan Announces that the FDA Accepts New Drug Application for Ulipristal Acetate for Uterine Fibroids
Allergan Announces that the FDA Accepts New Drug Application for Ulipristal Acetate for Uterine Fibroids
HSMN NewsFeed - 6 Oct 2017
Intezyne Closes Oversubscribed $10M Series A Financing to Drive Rapid Oncology Portfolio Development
Intezyne Closes Oversubscribed $10M Series A Financing to Drive Rapid Oncology Portfolio Development
HSMN NewsFeed - 29 Sep 2017
Lilly Announces Senior Leadership Appointments for Finance, Research & Development and Manufacturing
Lilly Announces Senior Leadership Appointments for Finance, Research & Development and Manufacturing
HSMN NewsFeed - 27 Sep 2017
Perrigo Announces First-To-Market Launch of the OTC Store Brand Equivalent Of Nexium(R) 24HR Capsules
Perrigo Announces First-To-Market Launch of the OTC Store Brand Equivalent Of Nexium(R) 24HR Capsules
HSMN NewsFeed - 21 Sep 2017
European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma
European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma
HSMN NewsFeed - 13 Sep 2017
Amarin Appoints Mark W. Salyer to New Position of Chief Commercial Officer
Amarin Appoints Mark W. Salyer to New Position of Chief Commercial Officer
HSMN NewsFeed - 12 Sep 2017
Vasorum Launches Celt ACD(R) Second Generation Vascular Closure Device in the USA
Vasorum Launches Celt ACD(R) Second Generation Vascular Closure Device in the USA
HSMN NewsFeed - 7 Sep 2017
Spinal Resources, Inc.'s Swedge Pedicle Screw System Receives FDA 510(k) Clearance
Spinal Resources, Inc.'s Swedge Pedicle Screw System Receives FDA 510(k) Clearance
HSMN NewsFeed - 16 Aug 2017
Perrigo Announces FDA Final Approval for its AB Rated Generic Version of Mycolog(R) II Cream
Perrigo Announces FDA Final Approval for its AB Rated Generic Version of Mycolog(R) II Cream
HSMN NewsFeed - 15 Aug 2017
Philips announces agreement with Lakeland Health for advanced monitoring to improve patient safety
Philips announces agreement with Lakeland Health for advanced monitoring to improve patient safety
HSMN NewsFeed - 14 Aug 2017
Biocept Enters Into Exclusive Distribution Agreement with Global Laboratory Product Supplier VWR
Biocept Enters Into Exclusive Distribution Agreement with Global Laboratory Product Supplier VWR
Additional items found! 500

Members Archive contains
500 additional stories matching:
Elan
(Password required)
Elan
(Password required)